Clinical Team Lead for Ambulatory Addiction Services - Social Work
About the job
- A Licensed Clinical Social Worker or Licensed Professional Counselor license with Mental Health Service Provider designation is required.
- The ability to supervise and manage Licensed Master Social Workers, Licensed Clinical Social Workers, and Certified Peer Recovery Specialists is required.
- At least three years of relevant experience in substance use and/or behavioral health treatment is required.
- Experience with individual and group therapy facilitation and crisis intervention is required.
- Competency with Microsoft Excel, project management tools, electronic medical records, and Microsoft Office is required.
- A Tennessee Licensed Clinical Social Worker certification is listed.
- A master's education level is listed.
- Collaborate with the Division Director, Deputy Director, and Lead Certified Peer Recovery Specialist in recruiting, interviewing, hiring, and onboarding new Licensed Clinical Social Worker, Licensed Master Social Worker, and Certified Peer Recovery Specialist team members.
- Conduct performance reviews.
- Manage caseload distribution, including therapy cases, State Opioid Response social work assignments, and daily appointment volume across program staff.
- Maintain a proportion of full-time-equivalent allocation for direct clinical work.
- Ensure Human Resources and Vanderbilt University Medical Center policies and procedures are followed within the VRC and Bridge clinic spaces.
- Standardize and monitor multidisciplinary team work processes.
- Provide professional leadership and management in the day-to-day execution of the VRC and Bridge clinics.
- Collaborate with division and medical leadership to align clinic operations with Vanderbilt Behavioral Health goals.
- Attend treatment team meetings and Bridge/VRC clinic huddles related to VISTA services.
- Assess and resolve clinical care issues, including providing crisis intervention, responding to patient care concerns, and partnering with leaders to resolve service-delivery barriers.
- Educate staff on policy and procedure changes related to clinical workflows and monitor implementation.
- Manage external referrals from community sites and screen for eligibility, placement, and scheduling.
- Manage optimal use of Epic and TNWITS by ensuring staff training and addressing workflow changes.
- Lead the audit process for TennCare health maintenance organizations, including WellCare, Amerigroup, and UnitedHealthcare.
- Provide direct and indirect supervision to social workers and Certified Peer Recovery Specialist team members.
- Serve as the authorizing provider for Licensed Master Social Workers and Certified Peer Recovery Specialists within the VRC and Bridge clinic spaces.
- Provide in-scope supervision to the Registered Nurse Case Manager in collaboration with Vanderbilt Psychiatric Hospital nursing leadership.
- Collaborate with the Deputy Director of the Middle Tennessee State Opioid Response Hub to review quality measures and initiatives, including BESMART enrollment and TennCare audits.
- Strategize, implement, and improve programs within VISTA and the Division of Addiction Psychiatry.
- Identify, evaluate, and implement strategies to improve programming, costs, and personnel distribution.
- Maintain professional documentation that meets department and Vanderbilt University Medical Center compliance standards.
- Provide brief targeted interventions for identified clients.
- Complete psychosocial assessments and assist the team with developing plans of care.
- Provide education and consultation to clients, families, treatment teams, and the community.
- Participate in process-improvement initiatives and shared decision-making.
- Conduct clinical counseling, patient evaluations, patient assessments, crisis intervention, and risk management.
- Develop staff and colleagues, maintain stakeholder relationships, communicate effectively, provide coaching and support, address quality issues, ensure continuous improvement, fulfill safety and regulatory requirements, manage resources, make data-driven decisions, apply technology, and adapt to change.
- Experience in a leadership or management position is preferred.
About the company
Vanderbilt Health runs a regional health system anchored by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. It delivers a broad spectrum of medical services—from primary care to specialized treatments—through hospitals and clinics across Middle Tennessee. The organization blends patient care with academic medicine, translating research into clinical practice and serving as a major training ground for medical professionals. Its competitive advantage comes from its strong research focus and academic affiliation with Vanderbilt University, attracting talent and patients seeking high-quality care. Revenue comes from clinical services, plus research grants and educational programs, with a goal of advancing medical knowledge while improving patient outcomes for the local and broader regional population.
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Nashville, Tennessee
Founded
1875
Get referred to Vanderbilt Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Siemens Healthineers signed Vanderbilt a $87 million imaging and oncology modernization deal on July 27, 2026.
- Rutherford County construction began July 12, 2026, expanding reach beyond Nashville.
- The August 2026 fertility alliance and Alzheimer AI project widen referral capture and innovation credibility.
What critics are saying
- The March 2026 phishing breach exposed data from 3,298 patients and invites OCR scrutiny.
- Rutherford hospital still faces execution risk after 2023 litigation delayed construction until 2028.
- Adding Jasmiry Bennett in November 2026 signals advanced-practice staffing strain across the enterprise.
What makes Vanderbilt Health unique
- Vanderbilt Health combines 43,000 employees, eight hospitals, and 180-plus clinics with academic medicine.
- Brock Center partnerships translate Vanderbilt research into clinical products, licensing, and startup access.
- Its training pipeline and specialty depth attract patients statewide, especially complex cases.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
401(k) Retirement Plan
Paid Vacation
Professional Development Budget
Company News
Scientist whose work revealed immune system-hypertension link to receive the 2026 Joseph A. Vita Award. Dr. Annet Kirabo of Vanderbilt Health to receive the 2026 Joseph A. Vita Award at American Heart Association Scientific Sessions 2026 Embargoed until 8 a.m. CT/9 a.m. ET, Wednesday, Sept. 30, 2026 DALLAS, Sept. 30, 2026 - A groundbreaking scientist whose discoveries revealed how immune activation and inflammation contribute to high blood pressure will be recognized by the American Heart Association at its annual Scientific Sessions in November. Annet Kirabo, D.V.M., Ph.D., FAHA, professor of medicine in the division of genetic medicine and clinical pharmacology at Vanderbilt Health, will receive the 2026 Joseph A. Vita Award at the American Heart Association's Scientific Sessions 2026. The meeting, to be held Nov. 6-9, 2026, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. Dr. Kirabo will be presented with the award during the Opening Session on Saturday, Nov. 7. Named after late cardiovascular scientist Joseph A. Vita, M.D., this award is presented annually to a scientist whose research has significantly advanced the fields of cardiovascular biology or cardiovascular health within the past five years and whose work has been published in the journals of the American Heart Association. Dr. Vita was the founding editor of the Heart Association's open-access, peer-reviewed Journal of the American Heart Association (JAHA). The award recipient is selected by the editors-in-chief of the Association's 14 peer-reviewed scientific journals and celebrates research that transforms or changes the direction of cardiovascular science. "Dr. Annet Kirabo exemplifies the spirit of the Joseph A. Vita Award, which recognizes research that changes the direction of cardiovascular science," said Manesh R. Patel, M.D., FAHA, the American Heart Association's 2026-2027 volunteer president, the Richard S. Stack, M.D. Distinguished Professor of Medicine, chief of the division of cardiology and vice president of heart and vascular services at Duke University in Durham, North Carolina. "Her pioneering discoveries represent a paradigm shift in cardiovascular biology, reshaping our understanding of hypertension by revealing how immune activation and inflammation drive cardiovascular disease. Through innovative, multidisciplinary research, she has uncovered potential therapeutic targets, including reactive lipid molecules called isolevuglandins and sodium-sensing pathways in immune cells, that have opened exciting possibilities for preventing and treating hypertension and related cardiovascular and kidney diseases." Dr. Kirabo is internationally recognized for discoveries that have redefined the role of immune activation and inflammation in hypertension and cardiovascular disease. Her groundbreaking research demonstrated that lipid oxidation-derived protein adducts, which are proteins altered when they bind to highly reactive molecules produced during the oxidation of fats, act as neoantigens that trigger antigen-presenting cell activation, T-cell responses, vascular dysfunction and hypertension. These discoveries fundamentally changed scientific understanding of how the immune system contributes to blood pressure regulation. Today, her laboratory combines immunology, vascular biology, genomics, metabolomics and single-cell technologies to identify new therapeutic strategies for cardiovascular and kidney disease. Her research spans the full spectrum of discovery science, from defining fundamental disease mechanisms to advancing translational research with the potential to transform patient care. With more than 230 scientific publications, sustained National Institutes of Health (NIH) funding and numerous influential articles published in the Heart Association's journals, Dr. Kirabo's work has established new directions in cardiovascular science and continues to influence investigators worldwide. Beyond her scientific discoveries, Dr. Kirabo has been an active Heart Association volunteer since 2009. She has served on the Council on Hypertension Communications Committee since 2018, including as chair from 2022 to 2024, and on the Council Operations Committee since 2024. She also has reviewed Association research proposals since 2017 and chaired sessions at scientific meetings in 2018, 2022 and 2023. Dr. Kirabo has served on the editorial board of the Hypertension journal since 2018 and as an associate editor of Circulation Research since 2019. "I am deeply honored to receive the Joseph A. Vita Award from the American Heart Association, an organization that has supported my career from my predoctoral and postdoctoral fellowships through my development as an independent investigator," said Dr. Kirabo. "Scientific discovery, mentorship and advancing new treatments for cardiovascular disease have been the primary focus of my career, and it is both rewarding and humbling to be recognized for it." Dr. Kirabo earned her doctor of veterinary medicine degree with honors from Makerere University in Uganda before completing a master of science in cell and molecular biology at St. Cloud State University in St. Cloud, Minnesota, and a doctorate in physiology and functional genomics at the University of Florida in Gainesville, Florida. She completed postdoctoral training in cardiovascular disease and inflammation at Vanderbilt University, where she now leads an internationally recognized research program and mentors the next generation of cardiovascular scientists. A dedicated mentor and educator, Dr. Kirabo has trained dozens of graduate students, postdoctoral fellows and early-career investigators, many of whom have gone on to faculty positions and independent research careers. Her commitment to mentorship, scientific collaboration and innovation continues to shape the future of cardiovascular research while expanding opportunities for emerging scientists around the world. Additional Resources: * Multimedia is available on the right column of the release link. * For more news at American Heart Association Scientific Sessions 2026, follow Louisiana Cardiology Associates LLC on X @HeartNews, #ScientificSessions26. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, Louisiana Cardiology Associates LLC fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, Louisiana Cardiology Associates LLC work tirelessly to advance health and transform lives every day. Connect with Louisiana Cardiology Associates LLC on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: American Heart Association Communications & Media Relations in Dallas: 214-706-1173; [email protected]
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X Accelerator for Behavioral Health and Addiction startups. Collaboration pairs Tampa Bay and Nashville's healthcare ecosystems, giving founders direct access to investors, researchers, clinicians, and licensing opportunities. September 23, 2026 13:58 ET | Source: Tampa Bay Wave TAMPA, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) - Tampa Bay Wave, a nonprofit, zero-equity startup accelerator, today announced a new partnership with Vanderbilt Health through the Brock Family Center for Applied Innovation to power its 2026 HealthTech|X cohort. The dual-region program will support startups building technology for behavioral health and addiction, two of the fastest-growing and most urgent categories in the industry. Through the partnership, founders selected for the cohort will have direct access to Vanderbilt researchers, clinicians, informaticists and health system leaders, along with paths to clinical research partnerships, technology transfer and licensing of Vanderbilt technologies. "Behavioral health and addiction don't leave room for ideas that only work on paper. Founders need clinicians willing to test their technology against real patients, fast. That's what Vanderbilt brings to this partnership, and paired with everything we've built in Tampa Bay, it gives these founders a shot most Accelerators can't offer," said Linda Olson, Founder and CEO, Tampa Bay Wave. "Vanderbilt Health and the Brock Center for Applied Innovation are excited to collaborate with Tampa Bay Wave to welcome innovative behavioral health and addiction-focused startups into the HealthTech|X cohort. Together, we look forward to connecting founders with Nashville's vibrant healthcare innovation ecosystem and providing exposure to Vanderbilt's world-class clinical, research, and entrepreneurial resources to accelerate their business progress," said Ken Holroyd, MD, MBA, Director of Brock Family Center for Applied Innovation at Vanderbilt Health. "Behavioral health and addiction are two critical areas of healthcare that need innovation from strong founders. The opportunity to pair two of the strongest HealthTech ecosystems in the United States in Tampa and Nashville is unique and a major inflection point for the Tampa Bay Wave, but most importantly provides an opportunity to rally investors, healthcare executives, and more to support the incoming cohort companies in a big way as they grow and scale their startups," said Richard Munassi, MD, MBA, Managing Director, Tampa Bay Wave. "The entire Brock family and Brock Recovery Group team is excited to see the launch of the 2026 HealthTech|X Accelerator program focused on Behavioral Health and Addiction startups. With pairing together a world class Accelerator in the Tampa Bay Wave with all that Nashville and the Brock Family Center for Innovation at Vanderbilt Health has to offer, along with the tremendous ecosystems of Tampa and Nashville, the program will undoubtedly be of high value to all the matriculating startups, now and into the future," said Major Brock, CEO, Brock Recovery Group. The 2026 HealthTech|X cohort will run across both Tampa and Nashville, with in-person session weeks in each city and virtual engagement between them, culminating in pitch nights in each market and a remote Demo Day. Tampa Bay Wave collaborates with a broader ecosystem of healthcare partners, including Tampa General Hospital, BayCare, USF Health, Moffitt Cancer Center and the Tampa Medical Research District. About Tampa Bay Wave Tampa Bay Wave, Inc. is a 501(c)(3) nonprofit providing entrepreneurs with facilitated access to the resources, expertise and capital they need to grow vibrant technology-based companies in Tampa Bay. Since 2013, Tampa Bay Wave has supported more than 670 tech startups that have raised more than $2 billion in capital, created more than 7,600 jobs and completed 34 exits, driving an estimated $450 million in annual economic impact, thanks to grant funding from the U.S. Economic Development Administration (EDA), National Oceanic and Atmospheric Administration (NOAA), and the U.S. Small Business Administration (SBA), plus support from its economic development partners Hillsborough County, Pasco County, and the City of Tampa. Tampa Bay Wave also receives support from individuals, corporations and foundations such as: A-LIGN, Appspace, Bank of America, Celestar, Delta Air Lines/Virgin Atlantic Airlines, Florida High Tech Corridor, Foley & Lardner, Justworks, Kuducom, Nielsen Foundation, NextPath Workforce Solutions, St. Petersburg College, TECO, Thoropass, the University of South Florida and others. In 2026, Tampa Bay Wave was ranked the #3 accelerator in the U.S. and #1 in Florida by TIME. For more information, visit tampabaywave.org. About Vanderbilt Health Vanderbilt Health, a growing academic health system headquartered in Nashville, Tennessee, is one of the largest and most prominent academic systems in the Southeast, providing patient care, conducting research and training the next generation of health professionals. With 43,000 employees, including 4,930 employed clinicians, Vanderbilt Health accommodated more than 3.5 million patient visits last year at its eight hospitals and 180-plus clinic locations. In 2025, Vanderbilt Health contributed $22.13 billion to the regional economy while also providing more than $1 billion in total community benefit and investment including patient financial assistance, medical research, health professional education, community grants and unreimbursed costs for government health programs. For more information, visit VanderbiltHealth.com.
Yale's jasmiry Bennett named Vice President and Chief Advanced Practice Officer for Vanderbilt Health. Jasmiry (Jas) Bennett, DNP, MBA, APRN, ACNP-BC, has been named the inaugural Vice President and Chief Advanced Practice Officer for Vanderbilt Health, according to an announcement Aug. 12 from System Chief Nursing Officer Karen Keady, PhD, RN, NEA-BC. Bennett, currently Advanced Practice Director at Yale New Haven Hospital, will begin her new role in November. "Dr. Bennett is a highly respected health care leader with more than 20 years of progressive experience in clinical practice, operations and executive leadership," Keady said. "Throughout her career, she has demonstrated a strong commitment to advancing the role of advanced practice providers, building high-performing teams, fostering interdisciplinary collaboration, and creating opportunities for APPs to practice at the top of their licensure." In her current role at Yale New Haven Hospital, Bennett provides strategic leadership across multiple clinical service lines and leads initiatives focused on quality, patient access, workforce development, operational excellence, and care delivery. She previously held leadership roles at Baylor Scott & White Health and Hackensack University Medical Center, where she helped establish and expand APP programs, strengthen governance structures, and drive innovative approaches to patient care and provider engagement. As Vanderbilt Health's first Vice President and Chief Advanced Practice Officer, Bennett will provide strategic leadership for the APP community across the enterprise and help shape the future of advanced practice. "Her ability to build strong relationships, lead transformational change, and align clinical and operational priorities will be invaluable as Vanderbilt Health continues to advance its mission of personalizing the patient experience through quality, innovation and discovery," Keady said. In the new role, Bennett will report directly to Keady, with a matrixed reporting relationship to Chief Medical Officer and Senior Vice President for Clinical Affairs Rick Wright, MD, and Chief of Staff for Corporate Clinical Affairs Cecelia Theobald, MD, MPH. "Dr. Bennett brings to Vanderbilt a wealth of experience leading advanced practice teams across multiple academic medical centers," Theobald said. "We are looking forward to how she will further enhance our already strong Vanderbilt Health culture and encourage us to continue to further develop these professions." "I look forward to the progress she will help us achieve in organizing our APP structure," Wright said.
Tennessee Fertility Institute announces patient services alliance with Vanderbilt Health. FinanceWire Aug. 20, 2026, 05:07 PM Nashville, TN, August 20th, 2026, FinanceWire Alliance expands access to comprehensive reproductive healthcare services for fertility patients throughout Tennessee Tennessee Fertility Institute (TFI), a leading provider of comprehensive fertility care, today announced a new patient services alliance with the Vanderbilt Health Fertility Clinic (VH) designed to support patients throughout their fertility treatment journey while leveraging the specialized expertise and resources of both organizations. Through the alliance, VH's reproductive endocrinologist Ryan Heitmann, D.O., will perform egg retrievals and embryo transfers at TFI. VH will continue to oversee patient care coordination and cycle monitoring, while TFI will provide the laboratory, embryology, cryopreservation, operating room and financial services associated with treatment. The alliance brings together VH's clinical care and patient management with TFI's advanced fertility infrastructure and laboratory services, providing patients with coordinated access to the resources needed throughout an IVF cycle. "Demand for high-quality fertility care continues to grow, and this alliance allows us to expand access while bringing together the strengths of two highly respected fertility programs," said Christopher Montville, M.D., Partner and Medical Director at TFI. "By combining Vanderbilt Health's clinical expertise with TFI's advanced laboratory and treatment capabilities, we can help more patients access the comprehensive care they need to build their families." TFI is part of The Prelude Network(R)(Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. "Our priority is ensuring patients receive exceptional, seamless care throughout every stage of their fertility journey," said Dr. Heitmann. "Working with TFI gives our patients access to advanced laboratory and treatment resources that meet rigorous quality and safety standards, while allowing our team to remain closely involved in their care from cycle planning and monitoring through treatment." Prelude is the clinical network of Inception Fertility(TM)(Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today's most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT). About Tennessee Fertility Institute Tennessee Fertility Institute (TFI) specializes in the treatment of male and female infertility, as well as LGBTQ+ and single parent fertility. The clinic offers comprehensive fertility assessment and testing services, and its full range of comprehensive fertility services include in vitro fertilization (IVF, intrauterine insemination (IUI), fertility preservation (including egg freezing, sperm freezing, and oncofertility), third-party reproduction and more. About The Prelude Network(R) The Prelude Network(R)(Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility(TM)- a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Fertility Houston (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). About Inception Fertility(TM) Inception Fertility(TM)(Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Its doctors are some of the first to use breakthrough assisted reproductive technologies (ART) - including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services - and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations - which includes The Prelude Network(R), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank(R), one of the largest frozen donor egg banks in North America; BUNDL Fertility(TM), a multi-cycle fertility service bundling program; HavenCryo(TM), a long-term reproductive preservation and storage solution provider and NutraBloom(R), a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception - Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. Media Contact Mia Humphreys [email protected] +1 239-297-6592 Contact. Media Contact Mia Humphreys Tennessee Fertility Institute [email protected] Sponsored Financial Content
Vanderbilt's AI initiative aims to reduce wait times for Alzheimer's patients. Vanderbilt Health, supported by a grant from Eli Lilly, is developing an AI-powered tool within their EHR system to expedite Alzheimer's treatment, focusing on reducing delays in monoclonal antibody therapy. Aug. 6, 2026 Vanderbilt Health has put together a project to accelerate the process of getting patients to Alzheimer's treatment, thanks to a grant from Eli Lilly and Company. The project is detailed in a news article by Paul Govern. Through the 18-month, $600,000 initiative, the team will develop an artificial intelligence (AI) tool inside their electronic health record system (EHR). The device will help reduce the time that patients wait to receive monoclonal antibody therapy after their healthcare provider refers them. Amalia Peterson, MD, Assistant Professor of Neurology and a co-principal investigator on the project told Govern that the AI agent will not replace clinical judgement. Instead, "it will remove a lot of the friction that keeps patients waiting." The agent will work by summarizing a patient's relevant chart information once they are recommended by a clinician for cognitive concern, and reporting gaps that might slow evaluation. It will also "recommend whether a case should be routed as priority or standard," however, "clinicians will retain the ability to accept, edit or override every recommendation." The team is considering developing additional AI agents within the EHR to streamline other areas of Alzheimer's care, but will first focus on helping patients receive their first monoclonal antibody infusion sooner. Managing Editor. Erin Brady is Managing Editor of Medical Laboratory Observer. The new frontier of point-of-care testing. Discover how next-generation handheld diagnostics are changing medicine at the speed of care. Get the Free eBook